Staphylococcus aureus, which is known as the most significant nosocomial pathogen and frequently causes postoperative wound infections, is a serious health issue in hospitals. Staphylococcusaureus has become increasingly drug resistant, and most of its strains have been shown to be resistant to practically all antibiotics. Numerous medical applications of aluminum oxide have been investigated, and this research indicates that the growth of Staphylococcus aureus may be inhibited in the presence of aluminumoxide nanoparticles.Methods: The study was conducted from March 2023 to the end of July 2023 at Al-Aziziya Hospital in Iraq.Using spectrophotometry on microtiter plates, biofilms were created in vitro. Single isolated organisms ofStaphylococcus aureus were examined for antibiotic susceptibility patterns using a conventional disk diffusion method. Furthermore, Prepared aluminum oxide nanoparticles were characterized using various techniques.Results: The results show that strongly inhibited growth of Staphylococcus aureus in the presence of aluminum oxide nanoparticles after 24 hours at 0.06125,0.1225 0.245, and 0.49 M. On the other hand, X-ray diffraction analysis revealed an average crystallite size of 35 nm for the aluminum oxide nanoparticles. TheFT-IR spectrum displayed prominent peaks at 615 and 636, corresponding to the stretching vibrations ofaluminum oxide. The EDX measurements confirmed the presence of aluminum (Al) and oxygen (O) peaks, indicating the purity of the sample.Conclusions: The antimicrobial assay demonstrated that the aluminum oxide nanoparticles exhibited significant antibacterial activity against Staphylococcus aureus. At a concentration of 0.06125 M of Al2O3,Staphylococcus aureus displayed a maximum zone of inhibition measuring 39 mm.